{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:47:55Z","timestamp":1774316875231,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ygyno.2016.10.006","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T20:54:47Z","timestamp":1476737687000},"page":"584-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial"],"prefix":"10.1016","volume":"143","author":[{"given":"Stella","family":"Capriglione","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Plotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Montera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Luvero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Aloisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovan Battista","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Angioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2016.10.006_bb0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2015.07.006","article-title":"Treatment of climacteric symptoms in survivors of gynaecological cancer","volume":"82","author":"Biglia","year":"2015","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.ygyno.2016.10.006_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of the North American menopause society menopause","volume":"19","author":"The North American Menopause Society (NAMS)","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2016.10.006_bb0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/13697137.2013.806471","article-title":"Estrogen therapy in gynecological cancer survivors","volume":"16","author":"Guidozzi","year":"2013","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.ygyno.2016.10.006_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.gyobfe.2012.02.015","article-title":"Management of hot flushes for breast cancer survivors","volume":"40","author":"Boutet","year":"2012","journal-title":"Gynecol. Obstet. Fertil."},{"issue":"3","key":"10.1016\/j.ygyno.2016.10.006_bb0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-016-3765-4","article-title":"Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions","volume":"156","author":"Johns","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.ygyno.2016.10.006_bb0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-015-3465-5","article-title":"Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis","volume":"152","author":"Ramaswami","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.ygyno.2016.10.006_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.maturitas.2012.07.010","article-title":"The management of menopausal symptoms in breast cancer survivors: case-based approach","volume":"73","author":"Lammerink","year":"2012","journal-title":"Maturitas"},{"issue":"35","key":"10.1016\/j.ygyno.2016.10.006_bb0040","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1200\/JCO.2010.29.9230","article-title":"Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors","volume":"28","author":"Bordeleau","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.10.006_bb0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinthera.2007.02.006","article-title":"Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review","volume":"29","author":"Bordeleau","year":"2007","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.ygyno.2016.10.006_bb0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11912-004-0037-y","article-title":"Management of hot flashes in breast cancer survivors and men with prostate cancer","volume":"6","author":"Stearns","year":"2004","journal-title":"Curr. Oncol. Rep."},{"issue":"4","key":"10.1016\/j.ygyno.2016.10.006_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1470-2045(00)00289-8","article-title":"Management of hot flashes in breast-cancer survivors","volume":"2","author":"Loprinzi","year":"2001","journal-title":"Lancet Oncol."},{"issue":"9247","key":"10.1016\/j.ygyno.2016.10.006_bb0060","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2016.10.006_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1188\/14.CJON.S3.59-67","article-title":"Hot flash management: update of the evidence for patients with cancer","volume":"18","author":"Kaplan","year":"2014","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.ygyno.2016.10.006_bb0070","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/GME.0b013e3182a66aa7","article-title":"Low-dose mesylate salt of paroxetine (7.5mg) for menopausal vasomotor symptoms: two randomized controlled trials","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.ygyno.2016.10.006_bb0075","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1245\/s10434-014-4263-8","article-title":"Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy","volume":"22","author":"Plotti","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2016.10.006_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejogrb.2014.03.041","article-title":"The effects of giving patients verbal or written pre-operative information in gynecologic oncology surgery: a randomized study and the medical-legal point of view","volume":"177","author":"Angioli","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.10.006_bb0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejogrb.2013.07.037","article-title":"Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy","volume":"170","author":"Angioli","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.10.006_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/IGC.0b013e3182842fc4","article-title":"Does extensive upper abdomen surgery during primary cytoreduction impact on long-term quality of life?","volume":"23","author":"Angioli","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2016.10.006_bb0095","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1345\/aph.1D610","article-title":"Non-estrogen treatment modalities for vasomotor symptoms associated with menopause","volume":"38","author":"Fugate","year":"2004","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.ygyno.2016.10.006_bb0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/11585360-000000000-00000","article-title":"Non-hormonal treatment strategies for vasomotor symptoms: a critical review","volume":"71","author":"Hall","year":"2011","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ygyno.2016.10.006_bb0105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0897190014544785","article-title":"A review of paroxetine for the treatment of vasomotor symptoms","volume":"28","author":"Slaton","year":"2015","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.ygyno.2016.10.006_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.maturitas.2016.02.015","article-title":"Personal and professional use of menopausal hormone therapy among gynecologists: a multinational study (REDLINC VII)","volume":"87","author":"Danckers","year":"2016","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.ygyno.2016.10.006_bb0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/gme.0b013e31818c91ca","article-title":"Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis","volume":"16","author":"Bardia","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2016.10.006_bb0120","doi-asserted-by":"crossref","DOI":"10.3399\/bjgp16X687097","article-title":"Best practice for HRT: unpicking the evidence","author":"Newson","year":"2016","journal-title":"Br J Gen Pract."},{"key":"10.1016\/j.ygyno.2016.10.006_bb0125","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/IJWH.S50804","article-title":"Critical appraisal of paroxetine for the treatment of vasomotor symptoms","volume":"7","author":"Carroll","year":"2015","journal-title":"Int. J. Women's Health"},{"key":"10.1016\/j.ygyno.2016.10.006_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1008382706068","article-title":"A pilot trial assessing the efficacy of paroxetine hydrocholoride (Paxil) in controlling hot flashes in breast cancer survivors","volume":"11","author":"Stearn","year":"2000","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.10.006_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0885-3924(02)00379-2","article-title":"A pilot trial of paroxetine for the treatment of the hot flashes and associated symptoms in women with breast cancer","volume":"23","author":"Weitzner","year":"2002","journal-title":"J. Pain Symptom Manag."},{"issue":"28","key":"10.1016\/j.ygyno.2016.10.006_bb0140","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1200\/JCO.2005.10.081","article-title":"Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial","volume":"23","author":"Stearns","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.10.006_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjmed.2007.10.007","article-title":"Paroxetine versus placebo for women in midlife after hormone discontinuation","volume":"121","author":"Soares","year":"2008","journal-title":"Am. J. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816314767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816314767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T09:52:51Z","timestamp":1536313971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816314767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0090825816314767"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.10.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}